Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKL.
Spohn
Gunther
G
Cytos Biotechnology, Zurich-Schlieren, Switzerland.
Bachmann
Martin F
MF
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000628:therapy*; D051379:Mice; D010024:Osteoporosis / Q000276:immunology / Q000628:therapy*; D053245:RANK Ligand / Q000276:immunology* / Q000378:metabolism; D014611:Vaccination; D014612:Vaccines / Q000009:adverse effects / Q000191:economics
D053245:RANK Ligand; D014612:Vaccines